Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 2013. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding the GlaxoSmithKline US Deferred Performance Share Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a specific equity transaction rather than general financial performance.
Material Changes
The filing reports an increase in the American Depositary Shares (ADSs) held by Mr. D E Troy. This increase resulted from the re-investment of the dividend paid to shareholders on July 11, 2013.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, risks, contingencies, or unusual items. It is a regulatory disclosure of a director's shareholding change.
Important Facts for Investors
- Transaction Date: July 17, 2013.
- Individual Involved: Mr. D E Troy.
- Transaction Type: Increase in ADS holdings via dividend re-investment.
- Price per ADS: $52.91.
- ADS Quantity: 262.233.
- Dividend Date: July 11, 2013.